Antibodies to acetylcholine receptor in parous women with myasthenia: Evidence for immunization by fetal antigen

Laboratory Investigation

Volumn 82, Issue 10, 2002, Pages 1407-1417

  Matthews, Ian ^a   Sims, Gary ^b   Ledwidge, Serena ^a   Stott, David ^b   Beeson, David ^a   Willcox, Nick ^a   Vincent, Angela ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; FETAL ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT;

ADULT; ANTIBODY SPECIFICITY; ARTHROGRYPOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL ARTICLE; CONSENSUS SEQUENCE; FEMALE; FETUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; MOLECULAR CLONING; MYASTHENIA GRAVIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THYMOCYTE;

ADULT; AMINO ACID SEQUENCE; AUTOANTIBODIES; BASE SEQUENCE; CHOLINERGIC ANTAGONISTS; COMPUTATIONAL BIOLOGY; FEMALE; FETAL PROTEINS; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, CHOLINERGIC;

EID: 0036796933     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000032379.63784.9C     Document Type: Article

References (54)

1. Beeson D, Jacobson L, Newsom-Davis J, and Vincent A (1996). A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis. Neurology 47:1552-1555.
2. Blanchette VS, Johnson J, and Rand M (2000). The management of alloimmune neonatal thrombocytopenic purpura. Baillère's Clin Haematol 13:365-390.
3. Bofill M, Janossy G, Willcox N, Chilosi M, Treijdosiewicz LK, and Newsom-Davis J (1985). Microenvironments in the normal and myasthenia gravis thymus. Am J Pathol 119:462-473.
4. Burges J, Wray DW, Pizzighella S, Hall Z, and Vincent A (1990). A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro. Muscle Nerve 13:407-413.
5. Chazenbalk GD, Portolano S, Russo D, Hutchison JS, Rapoport B, and McLachlan S (1993). Human organ-specific autoimmune disease: Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ. J Clin Invest 92:62-74.
6. Collet TA, Roben P, O'Kennedy R, Barbas CF, and Burton DR (1992). A binary plasmid system for shuffling combinatorial antibody libraries. Proc Natl Acad Sci USA 89:10026-10030.
7. de Wildt RMT, Hoet RMA, van Venrooij WJ, Tomlinson IM, and Winter G (1999). Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 285:895-901.
8. Dorrington KJ and Tanford C (1970). Molecular size and conformation of immunoglobulins. Adv Immunol 12:333-381.
9. Drachman DB (1994). Myasthenia gravis. N Engl J Med 330:1797-1810.
10. Farrar J, Portolano S, Willcox N, Vincent A, Jacobson L, Newsom-Davis J, Rapoport B, and McLachlan SM (1997). Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. Int Immunol 9:1311-1318.
11. + B cells. J Clin Invest 99:1614-1627.
12. Fostieri E, Beeson D, and Tzartos SJ (2000). The conformation of the main immunogenic region on the α-subunit of muscle acetylcholine receptor is affected by neighboring receptor subunits. FEBS Lett 481:127-130.
13. Graus YF, de Baets MH, Parren PWHI, Berrih-Aknin S, Wokke J, van Breda Vriesman PJ, and Burton DR (1997). Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. J Immunol 158:1919-1929.
14. Guo J, Wang Y, Jaume JC, Rapoport B, and McLachlan S (1999). Rarity of autoantibodies to a major autoantigen, thyroid peroxidase, that interact with denatured antigen or with epitopes outside the immunodominant region. Clin Exp Immunol 117:19-29.
15. Hall JM, Lingenfelter P, Adams SL, Lasser D, Hansen JA, and Bean MA (1995). Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 86:2829-2832.
16. Hall JG and Vincent A (2001). Arthrogryposis. In: Jones HR Jr, Darras BT, and De Vivo DC, editors. Neuromuscular disorders of infancy, childhood and adolescence. Woburn, MA: Butterworth Heinemann.
17. Heidenreich F, Vincent A, Willcox N, and Newsom-Davis J (1988). Anti-acetylcholine receptor antibody specificities in serum and in thymic culture supernatants from myasthenia gravis patients. Neurology 38:1784-1788.
18. Hesselmans L, Jennekens F, van den Oord C, Veldman H, and Vincent A (1993). Development of innervation of skeletal muscle fibers in man: Relation to acetylcholine receptors. Anat Rec 236:553-562.
19. Hoet RMA, Pieffers M, Stassen MHW, Raats J, de Wildt R, Pruijn GJM, van den Hoogen F, and van Venrooij WJ (1999). The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients. J Immunol 163:3304-3312.
20. Hougs L, Juul L, Ditzel HJ, Heilmann C, Svejgaard A, and Barington T (1999). The first dose of a Haemophilus influenzae b conjugate vaccine reactivates memory B cells: Evidence for extensive clonal selection, intraclonal affinity maturation, and multiple isotype switches to IgA2. J Immunol 162:224-237.
21. Jacobson L, Beeson D, Tzartos S, and Vincent A (1999b). Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform. J Neuroimmunol 98:112-120.
22. Jacobson L, Polizzi A, Morriss-Kay GM, and Vincent A (1999a). An animal model of antibody-mediated neurodevelopmental disease: Arthrogryposis multiplex congenita caused by antibodies to fetal acetylcholine receptor. J Clin Invest 103:1031-1038.
23. Jermy A, Beeson D, and Vincent A (1993). Pathogenic anti-(mouse) acetylcholine receptor induced in BALB/C mice without adjuvant. Eur J Immunol 23:973-976.
24. Kabat EA, Wu TT, Perry HM, Gottesman KS, and Foeller C (1991). Sequences of proteins of immunological interest, vol 2. Bethesda, MD: National Institutes of Heath.
25. Kornstein MJ, Brooks JJ, Anderson AO, Levinson AI, Lisak RP, and Zweiman B (1984). The immunohistology of the thymus in myasthenia gravis. Am J Pathol 117:184-194.
26. Kunkl A and Klaus GGB (1981). The generation of memory cells IV. Immunisation with antigen-antibody complexes accelerates the development of B memory cells, the formation of germinal centres and the maturation of antibody affinity in the secondary response. Immunology 43:371-378.
27. MacLennan ICM (1994). Germinal centres. Ann Rev Immunol 12:117-139.
28. Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, and Nelson JL (1999). Microchimerism of maternal origin persists into adult life. J Clin Invest 104:41-47.
29. Nelson JL (2001). HLA relationships of pregnancy, microchimerism and autoimmune disease. J Reprod Immunol 52:77-84.
30. Pichuri P, Guo J, Rapoport B, and McLachlan S (2001). Human monoclonal autoantibodies to B-cell epitopes outside the thyroid peroxidase autoantibody immunodominant region. Thyroid 11:301-313.
31. Polizzi A, Huson SM, and Vincent A (2000). Teratogen update: Maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology 62:332-341.
32. Riemersma S; Vincent A, Beeson D, Newland C, Hawke S, Vernet der Garabedian B, Eymard B, and Newsom-Davis J (1997) Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest 98:2358-2363.
33. Roxanis I, Micklem K, McConville J, Newsom-Davis J, and Willcox N (2002). Thymic myoid cells and germinal center formation in myasthenia gravis: Possible roles in pathogenesis. J Neuroimmunol 125:185-197.
34. Sanger F, Nicklen S, and Coulson AR (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
35. Schluep M, Willcox N, Vincent A, Dhoot GK, and Newsom-Davis J (1987). Acetylcholine receptors in human myoid cells in situ: An immunohistological study. Ann Neurol 22:212-222.
36. Serrano MPI, Cardona A, Vernet der Garabedian B, Bach J-F, and Pléau J-M. (1994). Nucleotide sequences of variable regions of a human anti-acetylcholine receptor autoantibody derived from a myasthenic patient. Mol Immunof 31:413-417.
37. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, and Weigert MG (1987). The role of clonal selection and somatic mutation in autoimmunity. Nature 328:805-811.
38. Sims GP, Shiono H, Willcox N, and Stott DI (2001). Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol 167:1935-1944.
39. Swofford DL (1993). PAUP: Phylogenetic analysis using parsimony, Version 3.1. Champaign, IL: Natural History Survey.
40. Tomlinson IM, Williams SC, Ignatovich O, Corbett SJ, and Winter G (1997). Human VBASE directory of immunoglobulin genes. Cambridge, UK: MRC Centre for Protein Engineering.
41. Tzartos SJ, Barkas T, Cung MT, Mamafaki A, Marraud M, Odewski P, Papanastasiou D, Sakarellos C, Sakareffos-Daitsiotis M, Tsantifi P, and Tsikaris V (1998). Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev 163:89-120.
42. Unwin N (2000). Nicotinic acetylcholine receptor and the structural basis of fast synaptic transmission. Phil Trans R Soc Lond B Biol Sci 355:1813-1829.
43. Vernet der Garabedian B, Lacokova M, Eymard B, Morel E, Faltin M, Zajac J, Sadovsky O, Dommergues M, Tripon P, and Bach JF (1994). Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J Clin Invest 94:555-559.
44. Vincent A, Buckley C, Dalton P, Clover L, Liguori R, Montagna P, McConville J, and Hoch W (2001). New antibodies to neuronal and muscle antigens. In: Vincent A and Martino G, editors. Autoantibodies in neurological diseases. Milan: Springer-Verlag, 19-27.
45. Vincent A, Newland C, Brueton L, Beeson D, Riemersma S, Huson SM, and Newsom-Davis J (1995). Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 346:24-25.
46. Vincent A and Newsom-Davis J (1985). Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 48:1246-1252.
47. Vincent A, Whiting PJ, Schluep M, Heidenreich F, Lang B, Roberts A, Willcox N, and Newsom-Davis J (1987). Antibody heterogeneity and specificity in myasthenia gravis. Ann NY Acad Sci 505:106-120.
48. Weigert M and Potter M (1977). Antibody variable region genetics: Summary and abstracts of homogeneous immunoglobulin workshop. Immunogenetics 4:401-435.
49. Weinberg CB and Hall ZW (1979). Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors. Proc Natl Acad Sci USA 76:504-508.
50. Whitacre CC (2001). Sex differences in autoimmunity. Nat Immunol 2:777-780.
51. Whiting PJ, Vincent A, and Newsom-Davis J (1986). Myasthenia gravis: Monoclonal anti-human acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment. Neurology 36:612-617.
52. Willcox HNA, Newsom-Davis J, and Calder LR (1983). Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes. Clin Exp Immunol 54:378-386.
53. Willcox N and Vincent A (1988). Myasthenia gravis as an example of organ-specific autoimmune disease. In: Bird G and Calvert JE, editors. B lymphocytes in human disease. Oxford: Oxford Medical Publications, Oxford University Press.
54. Winter G, Griffiths AD, Hawkins RE, and Hoogenboom HR (1994). Making antibodies by phage display technology. Ann Rev Immunol 12:433-455.